w66最给利老牌
About Us
w66最给利老牌:About Sino Biopharm
w66最给利老牌:Board of Directors
Senior Management
w66最给利老牌:R&D
R&D Team
w66最给利老牌:Products
w66最给利老牌:Product List
w66最给利老牌:Sustainability
w66最给利老牌:ESG Governance
w66最给利老牌:ESG Management Practices
w66最给利老牌:ESG Reports
w66最给利老牌:Investors
w66最给利老牌:Information Disclosure
w66最给利老牌:Corporate Governance
w66最给利老牌:Presentation
Investor FAQ
Notices
w66最给利老牌:News
w66最给利老牌:Press Releases
w66最给利老牌:Contact
CN
EN
Investors
Home
>
w66最给利老牌:Investors
>
Information Disclosure
w66最给利老牌:
Information Disclosure
w66最给利老牌:
Corporate Governance
Presentation
w66最给利老牌:
Investor FAQ
w66最给利老牌:
Notices
Information Disclosure
2016 Interim Report
2016.09.22
2015 ANNUAL REPORT
2016.04.28
2015 Interim Report
2015.09.25
2014 Annual Report
2015.04.27
2014 Interim Report
2014.09.24
2013 Annual Report
2014.04.22
2013 Interim Report
2013.09.23
2012 Annual Report
2013.04.23
首页
上一页
44
45
46
47
48
49
...
52
尾页
下一页
